Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
Cost of Revenue Over TimeStable
Percentile Rank50
3Y CAGR-36.2%
5Y CAGR-9.0%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-36.2%/yr
Annual compound
5Y CAGR
-9.0%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $61000.00 | - |
| 2024 | $0.00 | - |
| 2023 | $0.00 | -100.0% |
| 2022 | $235000.00 | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $98000.00 | +21.0% |
| 2019 | $81000.00 | - |